Universal Insurance director granted 3,414 shares

Universal Insurance Holdings director Michael Pietrangelo reported an equity award of company stock.

Rhea-AI Filing Summary

Universal Insurance Holdings director Michael Pietrangelo reported an equity award of company stock. He received 3,414 shares of common stock as a grant at a price of $0.00 per share, increasing his direct holdings to 84,707 shares.

The award consists of restricted shares that will vest on the earlier of June 11, 2027 or the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting. This is a compensation-related acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 3,414 shares

Grant/Award 1 txn

Insider PIETRANGELO MICHAEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,414	$0.00	$0.00

Holdings After Transaction: Common Stock — 84,707 shares (Direct)

Footnotes (1)

1. F1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Key Figures

Restricted share grant: 3,414 shares Grant price: $0.00 per share Holdings after transaction: 84,707 shares +2 more

5 metrics

Restricted share grant 3,414 shares Common Stock award to director on June 11, 2026

Grant price $0.00 per share Equity award, non-cash compensation

Holdings after transaction 84,707 shares Director’s direct ownership following the grant

Vesting date alternative 1 June 11, 2027 Time-based vesting trigger for restricted shares

Vesting date alternative 2 Next annual meeting If at least 50 weeks after prior year’s annual meeting

Key Terms

restricted shares, vest, annual meeting, Grant, award, or other acquisition

4 terms

restricted shares financial

"These restricted shares will vest on the earlier of (i) June 11, 2027..."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vest financial

"These restricted shares will vest on the earlier of (i) June 11, 2027..."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting financial

"the date of the next annual meeting that is at least 50 weeks after..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Universal Insurance Holdings (UVE) report for Michael Pietrangelo?

Universal Insurance Holdings director Michael Pietrangelo received 3,414 restricted shares of common stock as a grant at $0.00 per share. This award is a compensation-related acquisition, not an open-market purchase of shares on the stock exchange.

How many Universal Insurance Holdings (UVE) shares does Michael Pietrangelo hold after this Form 4?

After the reported grant, Michael Pietrangelo directly holds 84,707 shares of Universal Insurance Holdings common stock. This total includes the newly awarded 3,414 restricted shares, which are subject to future vesting conditions tied to time and the company’s annual meeting.

What are the vesting terms of Michael Pietrangelo’s restricted shares in Universal Insurance Holdings (UVE)?

The 3,414 restricted shares will vest on the earlier of June 11, 2027 or the date of the next annual meeting that is at least 50 weeks after the prior year’s annual meeting. Vesting determines when the director fully earns and can keep these shares.

Was cash paid for the Universal Insurance Holdings (UVE) shares reported in this Form 4?

No cash was paid for these shares. The 3,414 shares of Universal Insurance Holdings common stock were granted at $0.00 per share as an equity award, reflecting stock-based compensation to director Michael Pietrangelo rather than a cash purchase transaction.

Is Michael Pietrangelo’s Universal Insurance Holdings (UVE) transaction a buy or a compensation award?

The transaction is a compensation award, not a market buy. The Form 4 shows a code “A” grant of 3,414 restricted shares at $0.00 per share, categorized as a grant, award, or other acquisition related to Michael Pietrangelo’s role as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 05:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PIETRANGELO MICHAEL

(Last) (First) (Middle)

1110 WEST COMMERCIAL BOULEVARD

SUITE 100

(Street)

FORT LAUDERDALE FLORIDA 33309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL INSURANCE HOLDINGS, INC. [ UVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		3,414(1)	A	$0	84,707	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Remarks:

	/s/ Michael Pietrangelo	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)